Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001411920-16-000003
Filing Date
2016-05-13
Accepted
2016-05-12 20:12:19
Documents
1
Effectiveness Date
2016-05-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12587
  Complete submission text file 0001411920-16-000003.txt   13730
Mailing Address 140 W 57th St SUITE 3D New York NY 10019
Business Address 140 W 57th St SUITE 3D New York NY 10019 212-582-1199
IRX Therapeutics, Inc. (Filer) CIK: 0001411920 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-263122 | Film No.: 161645542